Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers [ATAC melanoma]

ABSTRACT: ATAC-seq was used to study the chromatin landscape of CD8 T cells in locally advanced melanoma patients treated with neo-adjuvant/adjuvant Pembrolizumab

ORGANISM(S): Homo sapiens

PROVIDER: GSE179606 | GEO | 2022/03/08

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers [RNA melanoma]

Project description:RNA-seq was used to study the transcriptional landscape of CD8 T cells in locally advanced melanoma patients treated with neo-adjuvant/adjuvant Pembrolizumab.

2022-03-08 | GSE179612 | GEO

IFN-gamma signature-driven neoadjuvant domatinostat, nivolumab and ipilimumab in stage III melanoma – the DONIMI trial

Project description:Low baseline Interferon gamma (IFNg) response signature is associated with lack of response to neo-adjuvant anti-PD1 + anti-CTLA4 therapy in patients with melanoma. Domatinostat, a class I specific histone deacetylase inhibitor is known to induce IFNg response in patients with advanced stage melanoma. Thus, addition of domatinostat to anti-PD1 + anti-CTLA4 might result in increased response to treatment. However, the effect of this combination therapy on tumor growth has not been evaluated in the pre-clinical setting. We therefore evaluated whether addition of domatinostat results in immune modulation and tumor growth control in the MeVa2.1.dOVA murine melanoma model. We provide pre-clinical evidence to use this combination in melanoma patients.

2023-03-13 | GSE217162 | GEO

Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers.

Project description:The clinical benefit of T cell immunotherapies remains limited by incomplete understanding of T cell differentiation and dysfunction. We generated an epigenetic and transcriptional atlas of T cell differentiation from healthy humans that included exhausted CD8 T cells and applied this resource in three ways. First, we identified modules of gene expression and chromatin accessibility, revealing molecular coordination of differentiation after activation and between central memory and effector memory. Second, we applied this healthy molecular framework to three settings-a neoadjuvant anti-PD1 melanoma trial, a basal cell carcinoma scATAC-seq dataset, and autoimmune disease-associated SNPs-yielding insights into disease-specific biology. Third, we predicted genome-wide cis-regulatory elements and validated this approach for key effector genes using CRISPR interference, providing functional annotation and demonstrating the ability to identify targets for non-coding cellular engineering. These studies define epigenetic and transcriptional regulation of human T cells and illustrate the utility of interrogating disease in the context of a healthy T cell atlas.

| S-EPMC9214622 | biostudies-literature

RNA-seq of human uveal melanoma cell lines 92-1, MP41 and UM22 treated with entinostat, JQ1 or DMSO

Project description:As part of the preclinical research for a recently published trial of combination therapy with the HDAC inhibitor entinostat and the PD1 inhibitor pembrolizumab, an experiment was performed to determined the influence of entinostat and the BET inhibitor JQ1 on the transcriptome of three uveal melanoma cell lines. The cell lines were cultured and treated with either entinostat, JQ1 or DMSO and subjected to RNA-seq for identification of differentially expressed genes.

2021-09-09 | E-MTAB-11058 | biostudies-arrayexpress

Tsur2019 - Response of patients with melanoma to immune checkpoint blockade

Project description:This is a simple mathematical population model for pembrolizumab-treated advanced melanoma patients, used to predict the response of melanoma patients to immune checkpoint inhibitors.

2024-09-02 | BIOMD0000000838 | BioModels

Melanoma Brain Metastasis Atlas

Project description:Melanoma Brain Metastasis Atlas

| PRJNA768859 | ENA

Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers [RNA melanoma]

Project description:Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers [RNA melanoma]

| PRJNA744268 | ENA

Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers [ATAC melanoma]

Project description:Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers [ATAC melanoma]

| PRJNA744258 | ENA

Tsur2019 - Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm

Project description:This is a simple mathematical model describing the interactions of an advanced melanoma tumor with both the immune system and the immunotherapy drug, pembrolizumab.

2019-11-15 | MODEL1911150001 | BioModels

Splicing patterns in SF3B1 mutated uveal melanoma generate shared immunogenic tumor-specific neo-epitopes [scADT-seq]

Project description:Purpose: In this study, we show that mutations of the splicing factor SF3B1 in uveal melanoma (UM) generate immunogenic neo-antigens.

2021-03-26 | GSE169605 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data